While the overexpression of METTL3, a key m6A methyltransferase, boosts sorafenib sensitivity in hepatocellular carcinoma by stabilizing FOXO3 mRNA via m6A methylation [43]. Here, FOXO3 is linked to hepatocellular carcinoma.